组织型激肽释放酶对大鼠急性脑缺血后GLUT-1表达的影响
摘要
激肽释放酶-激肽系统(kallikre in-kinin system,KKS)在人体分布广泛,发挥重要生理的作用,尤其在血管再生方面发挥重要作用[1]。本研究通过观察组织型激肽释放酶(TK)对脑缺血后 GLUT-1蛋白表达的影响,
出处
《中国实验诊断学》
2014年第7期1052-1053,共2页
Chinese Journal of Laboratory Diagnosis
基金
吉林省科技厅社会发展计划项目(No.20090463)
参考文献11
-
1Emam iN,Diam and isEP. Human tissue kallik reins: A road un-derconstrat ion[J]. Clin Chin Acta, 2007,381 (1) : 78.
-
2Longa EZ, Weintein PR. Carson S, et al. Rerersible middle Cere bral aetery occlusion without crainietomy in rats [J]. Stroke, 1989,20(1) :84.
-
3Xia CF, Yin H, Yao YY, et al. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis [ J ]. Hum Gene Ther, 2006, 17 : 206.
-
4Xia CF,Yin H,Borlongan CV,et al. Kallikrein gene transfer pro- tects afainst ischemic stroke by promoting glial cell migration and inhibiting apoptosis[J]. Hypertension, 2004,43 : 452.
-
5Murakami H, Yayama K, Miao RQ, et al. Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima forma- tion in the rat artery after balloon angioplasty[J]. Hypertension, 1999,34: 164.
-
6倪耀辉,丁素菊.组织型激肽释放酶对脑缺血大鼠神经和血管的影响[J].中国神经精神疾病杂志,2009,35(3):173-175. 被引量:2
-
7Nehlig A. Cerebral energy metabolism, glucose transport and blood flow:changes with maturation and adaplation tohypoglycae- mia[J]. Diabetes Metab, 1997,23(1) : 18.
-
8Simpson IA,Appel NM, Hokari M, et al. Blood-brain barrier glu- cose transporter: effects of hypo-and hyperglycemia revisited[J]. J Neurochem,1999,72(1) :238.
-
9Dobrogowska DH,Vorbrodt AW. Quantitative immunoeytochemical study of mouse brain[J]. J Histochem Cytochem, 1999,47 (8) : 1021.
-
10Regina A, Morechoisne S, Borson ND, et al. Factors released by glucose deprived astrocytes enhance glucose transporter expres- sion and activity in rat brain endothelia cells[J]. Biochim Biophys Acta, 2001,1540(3) : 233.
二级参考文献16
-
1Emami N, Diamandis EP. Human tissue kallikreins: A road under constration[ J]. Clin Chim Acta, 2007,381 (1) :78 -84.
-
2Yousef GM, Kishi T, Diamandis EP. Role of kallikrein enzymes in the central nervous system[ J]. Clin Chim Acta, 2003, 329 ( 1 - 2) : 1 -8.
-
3Longa EZ, Weinstein PR, Carlson L, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [ J ]. Stroke, 1989, 20(1) : 84-91.
-
4Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats[J]. Stroke, 2001, 32(4): 1005-1011.
-
5Gerriets T, Li F, Silva MD, et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats[J]. J Neurosci Methods, 2003, 122(2) : 201 -211.
-
6Lumenta DB, Plesnila N, Klasner B, et al. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia[J]. Brain Research, 2006,1069( 1 ) : 227 -234.
-
7Zausinger S, Lumenta DB, Pruneau D, et al. Effects of LF 16- 0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia[ J ]. Brain Res, 2002,950 ( 1 - 2) :268 - 278.
-
8Xia CF, Yin H, Borlongan CV. Kallikrein gene transfer protects against ischemia stroke by promoting glial cell migration and inhibiting apoptosis [ J ]. Hypertension, 2004,43 (2) : 452 - 459.
-
9Xia CF, Yin H, Yao YY, et al. Kallikrein protects against ischemia stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis[ J]. Human Gene Therapy, 2006, 17(2) :206 -219.
-
10Kochanek PM, Berger RP, Bayr H, et al. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making[J]. Curr Opin Crit Care, 2008, 14(2) :135 -141.
-
1章文莉,苏津自.激肽释放酶-激肽系统对心血管系统的保护作用[J].实用老年医学,2007,21(4):269-272. 被引量:1
-
2汪涛,康毅,娄建石.激肽释放酶-激肽系统的心血管领域研究进展[J].中国药理学与毒理学杂志,2003,17(6):466-470. 被引量:26
-
3张蕾,王莉,吴世政.激肽释放酶-激肽系统在中枢神经系统的研究进展[J].陕西医学杂志,2009,38(8):1073-1074. 被引量:1
-
4葛良,刘玲,杨昉,张仁良.激肽释放酶-激肽系统在血管平滑肌细胞增殖和迁移中的作用[J].国际脑血管病杂志,2012,20(7):551-554.
-
5朱洁,王迪,陈镜宇,吴华勋,魏伟.血浆激肽释放酶-激肽系统活化在大鼠佐剂性关节炎中的作用[J].安徽医科大学学报,2015,50(3):269-274.
-
6郑仁东,刘超.激肽释放酶-激肽系统与氧化应激[J].中国基层医药,2016,23(10):1584-1587. 被引量:1
-
7张家祥,王慧,许述海,沈彤,朱启星.PKSI-527对三氯乙烯致敏小鼠体内血浆激肽释放酶-激肽系统表达的影响[J].中国工业医学杂志,2016,29(4):284-288. 被引量:2
-
8王娟,咸华,丁敏,曹苏,沈施仁.吡那地尔预处理对大鼠皮肤-肌肉切口牵拉术后组织NGF和GLUT-1表达的影响[J].江苏医药,2014,40(13):1495-1497.
-
9李世峰,陈慧.激肽释放酶-激肽系统与血管内皮细胞功能关系研究新进展[J].心血管康复医学杂志,2005,14(5):508-510. 被引量:1
-
10顾天华,宋代军,郭冀珍,潘卫华.血管紧张素转换酶抑制剂影响自发性高血压大鼠肾功能的机制[J].中国药理学通报,1998,14(5):458-461. 被引量:1